Elevated C-reactive protein, erythrocyte sedimentation rate and other abnormal indicators may accompany malaria onset. Artemether is a prescription antimalarial drug, indicated for chloroquine-resistant falciparum malaria and severe falciparum malaria.
Artemether is priced higher than other antimalarials, as it is specifically used to treat severe falciparum malaria. Timely treatment is essential once such severe infections occur; otherwise, poor therapeutic outcomes and secondary complications may arise. Prescription drugs feature distinct pharmacological mechanisms. Whether administered via oral capsules, oral solutions or injections, artemether can be rapidly absorbed by the body. Nevertheless, adverse reactions may vary from person to person due to individual physical differences.
Strict compliance with medical advice is required during medication. Raw, cold, spicy and irritating foods should be avoided to prevent disease recurrence. This prescription drug may cause physical dependence. Dosage reduction or drug discontinuation may be considered appropriately when the patient's immunity and physical resistance recover sufficiently.
Artemether has specific contraindicated groups. It is prohibited for women in the first trimester of pregnancy, as it may cause transient abdominal distension and pain. Those with severely compromised immunity and physical resistance are also contraindicated. For further product information, please refer to the package insert, which is easy to understand. It is advisable to be familiar with basic properties of this active ingredient, including its chemical formula, boiling point and flash point.
